Thus, after binding to NK-1 receptors located in the neurons of the limbic system SP induces depression [54], and after binding to NK-1 receptors expressed in PC cells the same peptide elicits tumor cell proliferation and an antiapoptotic effect. Here, TACR1 is linked to depressive symptom measurement.